RegenEra Ventures
Venture capital
UncertainLast verified 7 Nov 2026
Global venture capital firm investing in early-stage biotech startups focused on regenerative medicine and diseases of ageing, primarily leading or co-leading Seed and Series A rounds in Europe.
0 deals in the last 24 months. Taken from its own website.
Key facts
- Stages
- Seed, Series A
- Sectors
- Biotech & pharma, Healthtech
- Eligible countries
- Not stated
- Timing
- Rolling applications
- Focus
- regenerative medicine; diseases of ageing; cardiometabolic therapeutics; neurodegenerative conditions; immunology and inflammation
- How to apply
- Apply route unknown
- Source
- https://regeneravc.com/
Recent deals
No deals in our data for the last 24 months.
Evidence
Short excerpts from the sources, in their original language, that back the facts above.
- Kind
RegenEra Ventures is a global VC fund focusing on early-stage biotech companies
https://regeneravc.com/ - Sectors
biotech companies in the field of regenerative medicine and diseases of ageing
https://regeneravc.com/ - Stages
lead/co-lead investor for Seed to Series A companies
https://regeneravc.com/
Status history
- 7 Nov 2026: Rolling → Uncertain (freshness: investor activity)
- 6 Nov 2026: Rolling (first extraction)
Something wrong or out of date? Report an error.
Work at RegenEra Ventures? Claim this profile to confirm what you invest in.